{"nct_id":"NCT06212752","title":"A Study of Subcutaneous (SC) Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) vs Intravenous Pembrolizumab in Adult Participants With Metastatic Non-small Cell Lung Cancer (NSCLC) (MK-3475A-D77)-Japan Extension","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-03","start_date":"2023-06-13","start_date_type":"ACTUAL","primary_completion_date":"2024-11-06","primary_completion_date_type":"ACTUAL","completion_date":"2028-05-22","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["MRK"]}